Abstract
Initially, intravenous immunoglobulins (IVIgs) were used as replacement therapy in primary and secondary antibody-deficiency syndromes. The clinical use of IVIg has been extended during the past decade to a wide variety of clinical conditions, such as infectious processes, neuroimmunological diseases, and different systemic autoimmune diseases. The mode of action of IVIg is complex, involving modulation of the Fc receptors, interference with the complement and cytokine network, and effects on the activation and differentiation of T-and B-cells.
Kawasaki disease (KD) was one of the first diseases within the group of primary vasculitides in which IVIg were used. Today, there is a clear evidence of benefit for IVIg in the treatment of coronary artery abnormalities related to KD. Subsequently, various reports have suggested a beneficial effect in other vasculitides; however, there are few data from controlled studies. For antineutrophil cytoplasmic antibody-associated vasculitis (AAV) one placebo-controlled and several open-label studies have shown a beneficial effect on the disease activity in patients with Wegener’s granulomatosis or microscopic polyangiitis refractory to standard therapy with prednisone and cyclophosphamide. For other vasculitides, such as polyarteritis nodosa or Henoch-Schonlein purpura, only case reports have described an inhibition of a disease progression by IVIg so far. However, the effect was partly only temporary. In conclusion, KD and AAV are the only vasculitides with a definite beneficial use of IVIg. For other vasculitides, the efficacy of IVIg has not been proven properly but may be useful in single cases.
Similar content being viewed by others
References
Patel, S. Y. and Kumararartne, D. S. (2001), Clin Exp Immunol 124, 169–171.
Rauch, A. M. (1987), Pediatr Infect Dis J 6, 1016–1021.
Leung, D. Y. M., Schlievert, P. M., and Meissner, H. C. (1998), Arthritis Rheum 41, 1538–1547.
Leung, D. Y. M., Siegel, R. L., Grady, S., et al. (1982), Clin Immunol Immunpathol 23, 100–112.
Furukawa, S., Matsubara, T., Jujoh, K., et al. (1988), Clin Exp Immunol 48, 247–251.
Ueno, Y., Takano, N., and Kanegane, H. (1989), Clin Exp Immunol 76, 337–342.
Leung, D. Y. M., Cotran, R. S., Kurt-Jones, E. A., Burns, J. C., Newburger, J. W., and Pober, J. S. (1989), Lancet 2, 1298–1302.
Marrack, P. and Kappler, J. (1990), Science 248, 705–711.
Choi, Y., Lafferty, J. A., Clements, J. R., et al. (1990), J Exp Med 172, 981–984.
Abe, J., Forrester, J., Nakahara, T., Lafferty, J. A., Kotzin, B. L., and Leung, D.Y. M. (1991), J Immunol 146, 3747–3750.
Leung, D. Y., Meissner, H. C., Fulton, D. R., Murray, D. L., Kotzin, B. L., and Schlievert, P. M. (1993), Lancet 9 93, 1385–1388.
Leung, D. Y. (1993), Curr Opion Rheumatol 5, 41–50.
Curtis, N. (2004), Adv Exp Med Biol 549, 191–200.
Takei, S., Arora, Y. K., and Walker, S. M. (1993), J Clin Invest 91, 602–607.
Lekova, E. S., Joffe, L., and Glode, M. P. (1990), Pediatr Infect Dis 9, 620–623.
Leucht, S., Uttenreuther-Fischer, M. M., Gaedicke, G., and Fischer, P. (2001), Clin Immunol 99, 18–29.
Optter, K. N., Li, Y., Mageed, R. A., Jefferies, R., and Capra, J. D. (1998), Mol Immunol. 35, 1179–1187.
Kazatchkine, M. D. and Kaveri, S. V. (2001), N Engl J Med 345, 747–755.
Rossi, F., Janye, D. R. W., Lockwood, C. M., and Kazatchkine, M. D. (1991), Clin Exp Immunol 83, 298–303.
Richter, C., Schnabel, A., Cernok, E., De Groot, K., Reinhold-Keller, E., and Gross, W. L. (1995), Clin Exp Immunol 101, 2–7.
Brooks, C. J., King, W. J., Radford, D. J., Adu, D., McGrath, M., and Savage, C. O. S. (1996), Clin Exp Immunol 106, 273–279.
Janye, D. R. W., Esnault, U. L. M., and Lockwood, C. M. (1993), J Autoimmun 6, 207–219.
Basta, M. (1996), Clin Exp Immunol 104, 21–25.
Kaveri, S., Vassilev, T., Hurez, V., et al. (1996), J Clin Invest 97, 865–869.
Kawasaki, T. (1967), Allergology 16, 178–222.
Newburger, J. W., Takahashi, M., Burns, J. C., et al. (1986), N Engl J Med 315, 341–347.
Furusho, K., Kamiya, T., Nakano, H., et al. (1984), Lancet 2, 1055–1058.
Furusho, K., Kamiya, T., Nakano, H., et al. (1984), Lancet 2, 1055–1058.
Newbuerger, J. W., Takahashi, M., Beiser, A. S., et al. (1991), N Engl J Med 324, 1633–1639.
Durongpisitkul, K., Guruang, V. J., Park, J. M., and Martin, C.F. (1995), Pediatrics. 96, 1057–1061.
Oates-Whitehead, R. M., Baumer, J. H., Haines, L., et al. (2003), Cochrane Database Syst Rev 4, CD004000.
Tse, S. M. L., Silverman, E. D., McCrindle, B. W., and Yeung, R. S. M. (2002), J Pediatr 140, 450–455.
Zhang, T., Yanagawa, H., and Nakumara, Y. (2002), Acta Paediatr 91, 517–520.
Burns, J. C. and Glode, M. P. (2004), Lancet 364, 533–544.
Burns, J. C., Edmund, V. C., Bown, J. A., Newburger, J. W., and Glode, M. P. (1998), Pediatr Infect Dis J 17, 1144–1148.
Wallace, C. A., French, J. W., Kahn, S. J., and Sherry, D. D. (2000), Pediatrics 150, E78.
Comenzo, R., Malachowski, M., Meissner, H. C., Fulton, D., and Berkman, E. (1992), J Pediatr 120, 926–928.
Terai, M. and Shulman, S. T. (1997), J Pediatr 131, 888–893.
Jayne, D. R. W., Black, C. M., Davies, M., Fox, C., and Lockwood, C. M. (1991), Lancet 337, 1137–1139.
Lockwood, C. M., Thiru, S., Isaacs, J., Hale, G., and Waldmann, H. (1993), Lancet 341, 1620–1622.
Jayne, D. R. W. and Lockwood, C. M. (1993), Adv Exp Med Biol 336, 469–472.
Jayne, D. R. W. and Lockwood, C. M. (1996), Br J Rheumatol 35, 1150–1153.
Jayne, D. R. W., Chapel, H., Adu, D., et al. (2000), Q J Med 93, 433–439.
Hamilos, D. L. and Christensen, J. (1991), J Allergy Clin Immunol 88, 823–824.
Lev, Y., George, J., Fabbrizzi, F., Rotman, P., Paz, Y., Shoenfeld, Y. (1999), South Med J 92, 412–414.
Armentia, A., Fernandez, A., Sanchez, P., et al. (1993), Allergol Immunopathol (Madr) 21, 47–52.
Orbach, H., Tishler, M., Shoenfeld, Y. (2004), Semin Arthritis Rheum 34, 593–601.
Muso, E., Toshiko, I. I., Takahiko, O., et al. (2004), Jpn J Infect Dis 57, S17-S18.
Viguier, M., Guillevin, L., and Laroche, L. (2001), N Engl J Med 344, 1481–1482.
Hamidou, M. A. Pottier, M. A., and Dupas, B. (1996), Ann Intern Med 125, 1013–1014.
Rostocker, G., Desvaux-Belghit,i D., Pilatte, Y., et al. (1994), Ann Intern Med 120, 476–484.
Stewart, R. R. C., Winney, R.J., and Cash, J. D. (1993), Vox Sang 65,244.
Jayne, D. (2001), Curr Opion Rheumatol 13, 48–55.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aries, P.M., Hellmich, B. & Gross, W.L. Intravenous immunoglobulin therapy in vasculitis. Clinic Rev Allerg Immunol 29, 237–245 (2005). https://doi.org/10.1385/CRIAI:29:3:237
Issue Date:
DOI: https://doi.org/10.1385/CRIAI:29:3:237